The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer ...

Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...

It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.

The Oncodetect test detects molecular residual disease across solid tumors using circulating tumor DNA to inform recurrence ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Don’t aspire to make a living. Let’s aspire to make a difference in the Mandarin/Cantonese-speaking community.” ...

In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in ...

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

Enhertu plus Perjeta demonstrated improvement in progression-free survival versus standard treatment in HER2-positive ...

I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.